Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Dec 03, 2019 12:41 PM IST | Source: PTI

Zydus receives tentative USFDA approval for Lorcaserin Hydrochloride Tabs

The company has received tentative approval from United States Food and Drug Administration (USFDA) to market the tablets in the strength of 10 mg, Zydus Cadila said in a filing to BSE.

Representative image
Representative image

Drug firm Zydus Cadila on Tuesday said that it has got a tentative approval from the US health regulator to market Lorcaserin Hydrochloride Tablets used in the treatment of obesity.

The company has received tentative approval from United States Food and Drug Administration (USFDA) to market the tablets in the strength of 10 mg, Zydus Cadila said in a filing to BSE.

The drug will be manufactured at the Group's formulations manufacturing facility at the Gujarat SEZ.

Close

The group now has 278 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04.

Shares of Cadila Healthcare, the listed entity of Zydus Group were today trading at Rs 255.15, down 1.16 per cent on the BSE.

Are you happy with your current monthly income? Do you know you can double it without working extra hours or asking for a raise? Rahul Shah, one of the India's leading expert on wealth building, has created a strategy which makes it possible... in just a short few years. You can know his secrets in his FREE video series airing between 12th to 17th December. You can reserve your free seat here.
First Published on Dec 3, 2019 12:35 pm
Loading...
Follow us on
Available On